BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2989948)

  • 21. Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.
    Galitzky J; Senard JM; Lafontan M; Stillings M; Montastruc JL; Berlan M
    Br J Pharmacol; 1990 Aug; 100(4):862-6. PubMed ID: 1976403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of alpha 1 adrenergic receptors in the canine prostate using [125I]-Heat.
    Lepor H; Baumann M; Shapiro E
    J Urol; 1987 Nov; 138(5):1336-9. PubMed ID: 2822972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-2A and alpha-2B adrenergic receptor subtypes: attenuation of cyclic AMP production in cell lines containing only one receptor subtype.
    Bylund DB; Ray-Prenger C
    J Pharmacol Exp Ther; 1989 Nov; 251(2):640-4. PubMed ID: 2553931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of alpha-2 adrenergic receptors and their regulation in rodent and porcine species.
    Feller DJ; Bylund DB
    J Pharmacol Exp Ther; 1984 Feb; 228(2):275-82. PubMed ID: 6141279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of alpha 1-adrenoceptor subtype selectivity by [3H]-prazosin displacement studies in guinea-pig cerebral cortex and rat spleen membranes.
    Veenstra DM; van Buuren KJ; Nijkamp FP
    Br J Pharmacol; 1992 Sep; 107(1):202-6. PubMed ID: 1358383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buffers differentially alter the binding of [3H]rauwolscine and [3H]RX821002 to the alpha-2 adrenergic receptor subtypes.
    Deupree JD; Hinton KA; Cerutis DR; Bylund DB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1215-27. PubMed ID: 8819505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of a yohimbine-agarose matrix useful for large-scale and micropurification of multiple alpha 2-receptor subtypes.
    Domino SE; Repaske MG; Bonner CA; Kennedy ME; Wilson AL; Brandon S; Limbird LE
    Methods Enzymol; 1992; 215():181-200. PubMed ID: 1359387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the alpha-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line.
    Blaxall HS; Murphy TJ; Baker JC; Ray C; Bylund DB
    J Pharmacol Exp Ther; 1991 Oct; 259(1):323-9. PubMed ID: 1656026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
    Snavely MD; Insel PA
    Mol Pharmacol; 1982 Nov; 22(3):532-46. PubMed ID: 6296651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of alpha 2-adrenergic receptors on rat pinealocytes.
    Schaad NC; Klein DC
    Endocrinology; 1992 May; 130(5):2804-10. PubMed ID: 1315259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning and expression of a rat brain alpha 2B-adrenergic receptor.
    Flordellis CS; Handy DE; Bresnahan MR; Zannis VI; Gavras H
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):1019-23. PubMed ID: 1704126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
    Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal alpha 1-adrenergic receptor subtypes: MDCK-D1 cells, but not rat cortical membranes possess a single population of receptors.
    Klijn K; Slivka SR; Bell K; Insel PA
    Mol Pharmacol; 1991 Mar; 39(3):407-13. PubMed ID: 1848662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium modulation of 3H-agonist and 3H-antagonist binding to alpha 2-adrenoceptor subtypes.
    MacKinnon AC; Spedding M; Brown CM
    Br J Pharmacol; 1993 Jun; 109(2):371-8. PubMed ID: 8102928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three distinct binding sites for [3H]-prazosin in the rat cerebral cortex.
    Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1991 Dec; 104(4):961-5. PubMed ID: 1687370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of agonists with platelet alpha 2-adrenergic receptors.
    Hoffman BB; Michel T; Brenneman TB; Lefkowitz RJ
    Endocrinology; 1982 Mar; 110(3):926-32. PubMed ID: 6120077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
    Lanier SM; Hess HJ; Grodski A; Graham RM; Homcy CJ
    Mol Pharmacol; 1986 Mar; 29(3):219-27. PubMed ID: 3005829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of alpha 2-adrenergic receptor sites in human retinoblastoma (Y-79) and neuroblastoma (SH-SY5Y) cells.
    Kazmi SM; Mishra RK
    Biochem Biophys Res Commun; 1989 Feb; 158(3):921-8. PubMed ID: 2537639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigations of prejunctional alpha 2-adrenoceptors in rat atrium, vas deferens and submandibular gland.
    Smith K; Connaughton S; Docherty JR
    Eur J Pharmacol; 1992 Feb; 211(2):251-6. PubMed ID: 1351849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.